Abaloparatide
CAS No.: 247062-33-5
Synonym: Tymlos
Mol. Formula: C₁₇₄H₃₀₀N₅₆O₄₉S
Mol. Weight: 3960.64 g/mol
ATC Code: H05AA05
Therapeutic Category: Osteoporosis Treatment
DMF Available: Yes
COA Available: Yes
FDA Approved: Yes
API Grade: IP/BP/USP
WHO GMP Approved: Yes

1) API Quality
Abaloparatide API is manufactured with advanced peptide synthesis technology to ensure high purity, stability, and consistent potency. Each batch undergoes strict testing for impurities, peptide sequence verification, residual solvents, sterility, and compliance with global regulatory standards.

2) Comprehensive Documentation
Full regulatory and technical documentation is offered, including:

DMF/CTD

COA (Certificate of Analysis)

Stability studies

GMP certificates

Peptide characterization reports

Validation and analytical method documents

This supports seamless regulatory submissions and global market approvals.

3) Secure Supply Chain
A controlled and traceable supply chain ensures uninterrupted delivery of Abaloparatide API. Temperature-controlled logistics, GMP-compliant storage, and backup sourcing systems maintain product integrity and reduce supply risks.

4) Manufacturer & Supplier Expertise
Produced by advanced peptide API manufacturers with strong core expertise, ensuring precision synthesis, stringent quality control, and scalable production capacity. Compliance with WHO-GMP and international quality norms ensures a reliable global supply.

5) Amber Lifesciences’ Role
Amber Lifesciences supports global pharmaceutical companies with high-quality Abaloparatide API, offering robust regulatory documentation, reliable supply, and expert technical assistance. With a strong quality framework and global reach, Amber Lifesciences is a trusted partner for peptide API sourcing.

Active Pharmaceutical Ingredient (API) – Not for Direct Human or Veterinary Use.